U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

ACIP Meetings
:: Next Posted Meeting Date – February 23-24, 2022

Press Announcements
November 12, 2021 – Coronavirus (COVID-19) Update: November 12, 2021


Vaccines and Related Biological Products Advisory Committee– FDA
No meetings on calendar

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Statement from President Joe Biden Announcing His Intention to Nominate Dr. Robert Califf for Commissioner of Food and Drugs
November 12, 2021 • Statements and Releases
I first want to thank Dr. Janet Woodcock for her leadership over the last year. She has done an incredible job leading the agency during what has been a busy and challenging time, and both she and the FDA career staff have worked hard and followed the science to ensure the American public can trust the decisions being made by the FDA.

Dr. Robert Califf is one of the most experienced clinical trialists in the country, and has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to put an end to the coronavirus pandemic. As the FDA considers many consequential decisions around vaccine approvals and more, it is mission critical that we have a steady, independent hand to guide the FDA. I am confident Dr. Califf will ensure that the FDA continues its science and data driven decision-making. Dr. Califf had strong bipartisan support in the Senate in 2016, and I urge the Senate to swiftly confirm Dr. Califf so he can continue the important work being done at this critical moment.

Dr. Robert Califf, Nominee for Commissioner of Food and Drugs
Dr. Califf is an internationally recognized expert in clinical trial research, health disparities, healthcare quality, and cardiovascular medicine. He brings nearly four decades of experience as a doctor, researcher, leader, and public servant, including previous service as FDA Commissioner from 2016-2017, for which he was confirmed by the Senate 89-4 with broad bi-partisan support. Currently, Califf is a professor of medicine at the Duke University School of Medicine, where he previously served as Vice Chancellor and founded the Duke Clinical Research Institute, and also works as Head of Clinical Policy at Verily Life Sciences, a life sciences research organization. Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
November 10, 2021 • Press Briefings

FACT SHEET: Biden Administration Announces New Investments to Support COVID-⁠19 Response and Recovery Efforts in the Hardest-Hit and High-Risk Communities and Populations as COVID-⁠19 Health Equity Task Force Submits Final Report
November 10, 2021 • Statements and Releases

Memorandum for the Secretary of Homeland Security and the Administrator of the Federal Emergency Management Agency on Maximizing Assistance to Respond to COVID-⁠19
November 09, 2021 • Presidential Actions


U.S. Department of State
Press Releases
Virtual COVID-19 Ministerial
November 10, 2021

Press Statement
Innovative Next Steps in the Global COVID-19 Response
Antony J. Blinken November 10, 2021

Press Statement
Chair’s Statement by U.S. Secretary of State Antony Blinken following the COVID-19 Ministerial
Antony J. Blinken November 10, 2021
[See Milestones/Perspectives above for detail]